Literature DB >> 18272347

Upregulation of heme oxygenase-1 in oral epithelial dysplasias.

J Lee1, S-K Lee, B-U Lee, H-J Lee, N-P Cho, J-H Yoon, H-R Choi, S-K Lee, E-C Kim.   

Abstract

The expression of heme oxygenase-1 (HO-1), stress-related enzyme, is induced in leukaemia and some cancer tissues, but relatively little is known about the differential pattern of HO-1 expression and proliferation in premalignant lesions of the epithelial oral mucosa. The purpose of this study was to evaluate whether HO-1 expression and proliferation were increased in preneoplastic lesions compared to normal and oral cancer tissues. Immunohistochemical staining was used to examine the expression patterns of HO-1 and proliferating cell nuclear antigen (PCNA) in a series of normal mucosa and mild-to-severe cases of oral epithelial dysplasia (OED) and oral squamous cell carcinoma. Both HO-1 and PCNA are expressed in the basal cells of normal oral mucosa. In patients with OED and carcinoma in situ, immunostaining for PCNA and HO-1 was more intense, and gradually extended into the superficial layers of the mucosa. HO-1 and PCNA expression was correlated with the degree of epithelial dysplasia. Oral squamous cell carcinoma also showed elevated expression of HO-1, but this level was not higher than in severe OED or carcinoma in situ. These results suggest that the up-regulation of HO-1 in premalignant oral lesions is part of an early cytoprotection mechanism against carcinogenesis in the oral mucosa.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18272347     DOI: 10.1016/j.ijom.2007.07.028

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  8 in total

1.  High expression of HO-1 predicts poor prognosis of ovarian cancer patients and promotes proliferation and aggressiveness of ovarian cancer cells.

Authors:  Z Zhao; Y Xu; J Lu; J Xue; P Liu
Journal:  Clin Transl Oncol       Date:  2017-08-14       Impact factor: 3.405

Review 2.  Heme oxygenase-1 system and gastrointestinal tumors.

Authors:  Xiao Zhu; Wen-Guo Fan; Dong-Pei Li; Marie C M Lin; Hsiangfu Kung
Journal:  World J Gastroenterol       Date:  2010-06-07       Impact factor: 5.742

Review 3.  The Nuclear Translocation of Heme Oxygenase-1 in Human Diseases.

Authors:  Qing Yang; Wenqian Wang
Journal:  Front Cell Dev Biol       Date:  2022-06-29

4.  Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis.

Authors:  Klaudia Skrzypek; Magdalena Tertil; Slawomir Golda; Maciej Ciesla; Kazimierz Weglarczyk; Guillaume Collet; Alan Guichard; Magdalena Kozakowska; Jorge Boczkowski; Halina Was; Tomasz Gil; Jaroslaw Kuzdzal; Lucie Muchova; Libor Vitek; Agnieszka Loboda; Alicja Jozkowicz; Claudine Kieda; Jozef Dulak
Journal:  Antioxid Redox Signal       Date:  2013-06-27       Impact factor: 8.401

5.  Heme oxygenase-1 expression in human gliomas and its correlation with poor prognosis in patients with astrocytoma.

Authors:  Norberto A Gandini; María E Fermento; Débora G Salomón; Diego J Obiol; Nancy C Andrés; Jean C Zenklusen; Julián Arevalo; Jorge Blasco; Alejandro López Romero; María M Facchinetti; Alejandro C Curino
Journal:  Tumour Biol       Date:  2014-03

6.  Involvement of heme oxygenase-1 in Korean colon cancer.

Authors:  Kyoung Ah Kang; Young Hee Maeng; Rui Zhang; Young Ro Yang; Mei Jing Piao; Ki Cheon Kim; Gi Young Kim; Young Ree Kim; Young Sang Koh; Hee Kyoung Kang; Chang Lim Hyun; Weon Young Chang; Jin Won Hyun
Journal:  Tumour Biol       Date:  2012-02-03

Review 7.  Can immunohistochemistry serve as an alternative to subjective histopathological diagnosis of oral epithelial dysplasia?

Authors:  Ahmad A Abdulmajeed; Camile S Farah
Journal:  Biomark Cancer       Date:  2013-10-10

8.  Heme oxygenase-1 promotes tumor progression and metastasis of colorectal carcinoma cells by inhibiting antitumor immunity.

Authors:  Geom Seog Seo; Wen-Yi Jiang; Jin Hua Chi; Hao Jin; Won-Chul Park; Dong Hwan Sohn; Pil-Hoon Park; Sung Hee Lee
Journal:  Oncotarget       Date:  2015-08-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.